Literature DB >> 28024217

Optimized procedures for manganese-52: Production, separation and radiolabeling.

Jesper Fonslet1, Sabrina Tietze1, Andreas I Jensen1, Stephen A Graves2, Gregory W Severin3.   

Abstract

Pressed chromium-powder cyclotron targets were irradiated with 16MeV protons, producing 52Mn with average yields of 6.2±0.8MBq/µAh. Separation by solid-phase anion exchange from ethanol-HCl mixtures recovered 94.3±1.7% of 52Mn and reduced the chromium content by a factor of 2.2±0.4×105. An additional AG 1-X8 column was used to remove copper, iron, cobalt and zinc impurities from the prepared 52Mn in 8M HCl. The macrocyclic chelator DOTA was rapidly radiolabeled with 52Mn in aq. ammonium acetate (pH 7.5R.T.) with a radiochemical yield >99% within 1min and was stable for >2 days in bovine serum. The improved separation and purification methodology facilitates the use of 52Mn in basic science and preclinical investigations.
Copyright © 2016. Published by Elsevier Ltd.

Entities:  

Keywords:  (52)Mn; Cyclotron; DOTA; Isotope production; Manganese; Mn-52; PET; Serum stability

Year:  2016        PMID: 28024217     DOI: 10.1016/j.apradiso.2016.11.021

Source DB:  PubMed          Journal:  Appl Radiat Isot        ISSN: 0969-8043            Impact factor:   1.513


  11 in total

1.  Half-life of 51Mn.

Authors:  Stephen A Graves; Paul A Ellison; Hector F Valdovinos; Todd E Barnhart; Robert J Nickles; Jonathan W Engle
Journal:  Phys Rev C       Date:  2017-07-18       Impact factor: 3.296

Review 2.  Expanding the PET radioisotope universe utilizing solid targets on small medical cyclotrons.

Authors:  K J H George; S Borjian; M C Cross; J W Hicks; P Schaffer; M S Kovacs
Journal:  RSC Adv       Date:  2021-09-21       Impact factor: 4.036

3.  ImmunoPET: Concept, Design, and Applications.

Authors:  Weijun Wei; Zachary T Rosenkrans; Jianjun Liu; Gang Huang; Quan-Yong Luo; Weibo Cai
Journal:  Chem Rev       Date:  2020-03-23       Impact factor: 60.622

Review 4.  PET radiometals for antibody labeling.

Authors:  Eduardo Aluicio-Sarduy; Paul A Ellison; Todd E Barnhart; Weibo Cai; Robert Jerry Nickles; Jonathan W Engle
Journal:  J Labelled Comp Radiopharm       Date:  2018-03-12       Impact factor: 1.921

5.  Biodistribution and PET Imaging of pharmacokinetics of manganese in mice using Manganese-52.

Authors:  A Lake Wooten; Tolulope A Aweda; Benjamin C Lewis; Rebecca B Gross; Suzanne E Lapi
Journal:  PLoS One       Date:  2017-03-17       Impact factor: 3.240

6.  Manganese-52: applications in cell radiolabelling and liposomal nanomedicine PET imaging using oxine (8-hydroxyquinoline) as an ionophore.

Authors:  Peter Gawne; Francis Man; Jesper Fonslet; Riya Radia; Jayanta Bordoloi; Matthew Cleveland; Pilar Jimenez-Royo; Alberto Gabizon; Philip J Blower; Nicholas Long; Rafael T M de Rosales
Journal:  Dalton Trans       Date:  2018-07-17       Impact factor: 4.390

Review 7.  Manganese in PET imaging: Opportunities and challenges.

Authors:  Marie Brandt; Jens Cardinale; Ivo Rausch; Thomas L Mindt
Journal:  J Labelled Comp Radiopharm       Date:  2019-06-30       Impact factor: 1.921

Review 8.  The chemical tool-kit for molecular imaging with radionuclides in the age of targeted and immune therapy.

Authors:  Timothy H Witney; Philip J Blower
Journal:  Cancer Imaging       Date:  2021-01-30       Impact factor: 3.909

9.  Characterization of actinide resin for separation of 51,52gMn from bulk target material.

Authors:  Kendall E Barrett; Eduardo Aluicio-Sarduy; Steffen Happel; Aeli P Olson; Christopher J Kutyreff; Paul A Ellison; Todd E Barnhart; Jonathan W Engle
Journal:  Nucl Med Biol       Date:  2021-03-03       Impact factor: 2.408

10.  A New Oxygen Containing Pyclen-Type Ligand as a Manganese(II) Binder for MRI and 52Mn PET Applications: Equilibrium, Kinetic, Relaxometric, Structural and Radiochemical Studies.

Authors:  Tibor Csupász; Dániel Szücs; Ferenc Krisztián Kálmán; Oldamur Hollóczki; Anikó Fekete; Dezső Szikra; Éva Tóth; Imre Tóth; Gyula Tircsó
Journal:  Molecules       Date:  2022-01-07       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.